PubMed for Bookshelf ID: 4721468

Year	Number of Results
2002	1
2004	1
2005	1
2009	1
2011	1
2012	2
2013	3
2014	3
2015	1
2016	7
2017	11
2018	4
2019	1
2020	1
2024	0

1

Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans.

Shah V, Yang C, Shen Z, Kerr BM, Tieu K, Wilson DM, Hall J, Gillen M, Lee CA. Shah V, et al. Xenobiotica. 2019 Jul;49(7):811-822. doi: 10.1080/00498254.2018.1504257. Epub 2018 Sep 12. Xenobiotica. 2019. PMID: 30117757 Clinical Trial.

2

Recent pharmacological advances in the management of gout.

Davies K, Bukhari MAS. Davies K, et al. Rheumatology (Oxford). 2018 Jun 1;57(6):951-958. doi: 10.1093/rheumatology/kex343. Rheumatology (Oxford). 2018. PMID: 28968896 Review.

3

Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Hill-McManus D, Soto E, Marshall S, Lane S, Hughes D. Hill-McManus D, et al. Br J Clin Pharmacol. 2018 Jan;84(1):142-152. doi: 10.1111/bcp.13427. Epub 2017 Oct 10. Br J Clin Pharmacol. 2018. PMID: 28888218 Free PMC article.

4

Current and future therapies for gout.

Pascart T, Richette P. Pascart T, et al. Expert Opin Pharmacother. 2017 Aug;18(12):1201-1211. doi: 10.1080/14656566.2017.1351945. Epub 2017 Jul 28. Expert Opin Pharmacother. 2017. PMID: 28689430 Review.

5

Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.

Soskind R, Abazia DT, Bridgeman MB. Soskind R, et al. Expert Opin Pharmacother. 2017 Aug;18(11):1115-1125. doi: 10.1080/14656566.2017.1349099. Epub 2017 Jul 9. Expert Opin Pharmacother. 2017. PMID: 28658988 Review.

6

Allopurinol Therapy and HLA-B*58:01 Genotype.

Dean L, Kane M. Dean L, et al. 2013 Mar 26 [updated 2020 Dec 9]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2013 Mar 26 [updated 2020 Dec 9]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 28520356 Free Books & Documents. Review.

7

Treatment Options for Gout.

Engel B, Just J, Bleckwenn M, Weckbecker K. Engel B, et al. Dtsch Arztebl Int. 2017 Mar 31;114(13):215-222. doi: 10.3238/arztebl.2017.0215. Dtsch Arztebl Int. 2017. PMID: 28434436 Free PMC article. Review.

8

Lesinurad: A Review in Hyperuricaemia of Gout.

Deeks ED. Deeks ED. Drugs Aging. 2017 May;34(5):401-410. doi: 10.1007/s40266-017-0461-y. Drugs Aging. 2017. PMID: 28425024 Review.

9

Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 3: Treatment.

Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P. Schlee S, et al. Z Gerontol Geriatr. 2018 Aug;51(6):703-710. doi: 10.1007/s00391-017-1199-1. Epub 2017 Feb 28. Z Gerontol Geriatr. 2018. PMID: 28246893 Review. English.

10

Lesinurad: A significant advancement or just another addition to existing therapies of gout?

Gupta A, Sharma PK, Misra AK, Singh S. Gupta A, et al. J Pharmacol Pharmacother. 2016 Oct-Dec;7(4):155-158. doi: 10.4103/0976-500X.195897. J Pharmacol Pharmacother. 2016. PMID: 28163535 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year